Similar articles for PMID: 18928937

Year	Number of Results
1955	3
1956	1
1958	2
1959	1
1960	1
1962	1
1963	1
1968	1
1972	1
1973	1
1977	1
1978	1
1979	1
1981	2
1982	1
1983	2
1984	1
1985	2
1988	1
1989	3
1990	4
1991	3
1992	3
1993	3
1994	2
1995	5
1996	12
1997	3
1998	4
1999	5
2000	2
2001	3
2002	4
2003	13
2004	11
2005	26
2006	17
2007	33
2008	42
2009	37
2010	12
2011	12
2012	11
2013	7
2014	11
2015	8
2016	10
2017	6
2018	7
2019	6
2020	2
2021	12
2022	7
2024	0

1

Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.

Karl J, Wild N, Tacke M, Andres H, Garczarek U, Rollinger W, Zolg W. Karl J, et al. Clin Gastroenterol Hepatol. 2008 Oct;6(10):1122-8. doi: 10.1016/j.cgh.2008.04.021. Clin Gastroenterol Hepatol. 2008. PMID: 18928937

2

Stool test for colorectal cancer screening--it's time to move!

Loitsch SM, Shastri Y, Stein J. Loitsch SM, et al. Clin Lab. 2008;54(11-12):473-84. Clin Lab. 2008. PMID: 19216253 Review.

3

Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.

Takai T, Kanaoka S, Yoshida K, Hamaya Y, Ikuma M, Miura N, Sugimura H, Kajimura M, Hishida A. Takai T, et al. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1888-93. doi: 10.1158/1055-9965.EPI-08-0937. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19505922

4

Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.

Limburg PJ, Devens ME, Harrington JJ, Diehl NN, Mahoney DW, Ahlquist DA. Limburg PJ, et al. Am J Gastroenterol. 2003 Oct;98(10):2299-305. doi: 10.1111/j.1572-0241.2003.07630.x. Am J Gastroenterol. 2003. PMID: 14572583

5

Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).

Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH. Hoff G, et al. Gut. 2004 Sep;53(9):1329-33. doi: 10.1136/gut.2004.039032. Gut. 2004. PMID: 15306594 Free PMC article. Clinical Trial.

6

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E. Quintero E. Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Gastroenterol Hepatol. 2009. PMID: 19577340 Review. Spanish.

7

[Fecal oncomarkers in the diagnostics of colorectal cancer].

Mikhaĭlova EI, Pimanov SI, Voropaev EV. Mikhaĭlova EI, et al. Klin Med (Mosk). 2007;85(12):62-7. Klin Med (Mosk). 2007. PMID: 18318171 Russian.

8

A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.

Johne B, Kronborg O, Tøn HI, Kristinsson J, Fuglerud P. Johne B, et al. Scand J Gastroenterol. 2001 Mar;36(3):291-6. Scand J Gastroenterol. 2001. PMID: 11305517 Clinical Trial.

9

Noninvasive testing for colorectal cancer: a review.

Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE. Ouyang DL, et al. Am J Gastroenterol. 2005 Jun;100(6):1393-403. doi: 10.1111/j.1572-0241.2005.41427.x. Am J Gastroenterol. 2005. PMID: 15929776 Review.

10

Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.

Haug U, Hundt S, Brenner H. Haug U, et al. Am J Gastroenterol. 2010 Mar;105(3):682-90. doi: 10.1038/ajg.2009.668. Epub 2009 Dec 1. Am J Gastroenterol. 2010. PMID: 19953091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

347 results

Results by year